These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14520121)

  • 21. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased oxidative stress in epileptic children treated with valproic acid.
    Verrotti A; Scardapane A; Franzoni E; Manco R; Chiarelli F
    Epilepsy Res; 2008 Feb; 78(2-3):171-7. PubMed ID: 18164182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with persistent thrombocytopenia after liver transplantation.
    Stanca CM; Fiel MI; Aledort L; Cohen E; del Rio Martin J; Schiano TD
    Transplant Proc; 2010 Jun; 42(5):1769-73. PubMed ID: 20620520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid.
    Arslan M; Vurucu S; Balamtekin N; Unay B; Akin R; Kurt I; Ozcan O
    Brain Dev; 2009 Jun; 31(6):405-10. PubMed ID: 18814980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M; Yakinci C
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrocytosis associated with divalproex treatment.
    Tsivkin R; Saito E; Kafantaris V
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1011-4. PubMed ID: 16379522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal volume measurement in older adults with bipolar disorder.
    Beyer JL; Kuchibhatla M; Payne ME; Moo-Young M; Cassidy F; Macfall J; Krishnan KR
    Am J Geriatr Psychiatry; 2004; 12(6):613-20. PubMed ID: 15545329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for development of subclinical hypothyroidism during valproic acid therapy.
    Mikati MA; Tarabay H; Khalil A; Rahi AC; El Banna D; Najjar S
    J Pediatr; 2007 Aug; 151(2):178-81. PubMed ID: 17643774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
    Loiseau P
    Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.
    Münster P; Marchion D; Bicaku E; Schmitt M; Lee JH; DeConti R; Simon G; Fishman M; Minton S; Garrett C; Chiappori A; Lush R; Sullivan D; Daud A
    J Clin Oncol; 2007 May; 25(15):1979-85. PubMed ID: 17513804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
    Kauer-Sant'Anna M; Bond DJ; Lam RW; Yatham LN
    Compr Psychiatry; 2009; 50(1):1-8. PubMed ID: 19059506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.